MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
Preprint
Abstract
Hereditary α-tryptasemia (HαT), defined by increased TPSAB1 copy number and elevated basal serum tryptase, is associated with mast cell (MC)–mediated symptoms, yet its role in gastrointestinal disease remains unclear. Because intestinal MCs express the non-IgE–dependent activation receptor MRGPRX2, we investigated whether MRGPRX2 expression is altered in individuals with HαT and inflammatory bowel disease (IBD). We genotyped 854 biobanked IBD samples, performed spatial transcriptomics on descending colon tissue (n = 4 HαT; n = 4 non-HαT), and analyzed small-intestinal biopsies by mass cytometry (CyTOF; n = 5 HαT; n = 9 controls). Across these complementary platforms, HαT was associated with increased gastrointestinal MC abundance and higher expression of activation markers including CD203c, LAMP-1, and SIGLEC8. Both spatial transcriptomics and ddPCR demonstrated significantly increased MRGPRX2 and SIGLEC8 transcripts in IBD samples from individuals with HαT compared with matched non-HαT IBD cases. These findings suggest that enhanced MRGPRX2 expression and associated MC activation may contribute to gastrointestinal symptoms in HαT, particularly in the context of IBD. As interest in precision immunogenetics grows, defining MC phenotypes linked to α-tryptase copy number may help refine diagnostic evaluation and identify patients who could benefit from emerging mast cell–targeted therapeutic strategies in the context of IBD.Keywords
This publication has 54 references indexed in Scilit:
- Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell–Mediated ReactionsCurrent Allergy and Asthma Reports, 2024
- Clinical relevance of inherited genetic differences in human tryptasesAnnals of Allergy, Asthma & Immunology, 2021
- Mast cell tryptases in allergic inflammation and immediate hypersensitivityCurrent Opinion in Immunology, 2021
- Inherited and acquired determinants of serum tryptase levels in humansAnnals of Allergy, Asthma & Immunology, 2021
- Understanding mast cell heterogeneity at single cell resolutionTrends in Immunology, 2021
- Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugsCurrent Opinion in Immunology, 2021
- Spatiotemporal analysis of human intestinal development at single-cell resolutionCell, 2021
- Mast cell activation in the context of elevated basal serum tryptase: genetics and presentationsCurrent Allergy and Asthma Reports, 2019
- An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe AsthmaCell, 2019
- Hereditary Alpha TryptasemiaImmunology and Allergy Clinics of North America, 2018